GB940260A - Antitrachoma vaccine - Google Patents
Antitrachoma vaccineInfo
- Publication number
- GB940260A GB940260A GB35355/62A GB3535562A GB940260A GB 940260 A GB940260 A GB 940260A GB 35355/62 A GB35355/62 A GB 35355/62A GB 3535562 A GB3535562 A GB 3535562A GB 940260 A GB940260 A GB 940260A
- Authority
- GB
- United Kingdom
- Prior art keywords
- virus
- suspension
- antitrachoma
- vaccine
- separated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
An antitrachoma vaccine is prepared by inoculating a chicken egg with trachomatous material, culturing, suspending the infected yolk sac membranes in an aqueous trypsin suspension in aqueous phosphate buffer solution at pH 7.5 to 8 and 35 DEG to 40 DEG C. to free the virus from the protein. The viral suspension is separated from the protein fraction and further treated with silicious material to absorb impurities. It is then separated from the silicious material and finally treated with a fat solvent such as diethyl ether. The separation of the virus may be by differential centrifuging. The final virus suspension may be used as such or in admixture with aluminium hydroxide or mineral oils.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1697161 | 1961-09-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB940260A true GB940260A (en) | 1963-10-30 |
Family
ID=11149600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB35355/62A Expired GB940260A (en) | 1961-09-20 | 1962-09-17 | Antitrachoma vaccine |
Country Status (4)
| Country | Link |
|---|---|
| BR (1) | BR6243116D0 (en) |
| CH (1) | CH433595A (en) |
| FR (1) | FR2021M (en) |
| GB (1) | GB940260A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4328208A (en) * | 1981-05-20 | 1982-05-04 | Kurbanov Ildus A | Vaccine against chlamydous infections of farm animals |
-
1962
- 1962-09-17 GB GB35355/62A patent/GB940260A/en not_active Expired
- 1962-09-17 CH CH1097862A patent/CH433595A/en unknown
- 1962-09-17 BR BR143116/62A patent/BR6243116D0/en unknown
- 1962-09-18 FR FR909722A patent/FR2021M/en active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4328208A (en) * | 1981-05-20 | 1982-05-04 | Kurbanov Ildus A | Vaccine against chlamydous infections of farm animals |
Also Published As
| Publication number | Publication date |
|---|---|
| CH433595A (en) | 1967-04-15 |
| FR2021M (en) | 1963-09-16 |
| BR6243116D0 (en) | 1973-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB607787A (en) | Improvements in and relating to the concentration or thickening of liquids containing solid matter in suspension | |
| Whitehead et al. | The “third component” or heat-stable factor of complement | |
| Holtermann et al. | The development of soluble (S) and viral (V) antigens of influenza A virus in tissue culture as studied by the fluorescent antibody technique. 1. Studies employing a low multiplicity of infection in beef embryo kidney cells | |
| GB940260A (en) | Antitrachoma vaccine | |
| GB980227A (en) | Purification and/or concentration of material containing interferon | |
| GB1498261A (en) | Influenza vaccines | |
| GB1062434A (en) | Process for isolating -antitrypsin | |
| GB1096951A (en) | Vaccines comprising inactivated myxoviruses | |
| US3876764A (en) | Vaccines for infectious pustular vulvovaginitis | |
| GB1082862A (en) | A process in filtering yeast or other plant cell material | |
| GB811411A (en) | Process for the production of a tissue culture fluid containing infectious hepatitisvirus and a killed vaccine therefrom | |
| GB953992A (en) | Vaccine products and method of preparing same | |
| McClung | A technique for the production of immune sera for Paramecium aurelia | |
| CA522851A (en) | Method of separating solids from aqueous suspensions | |
| SU92203A1 (en) | The method of obtaining hydrophilic surfaces from synthetic rubber | |
| AT243502B (en) | Process for the preparation of aqueous dispersions with positively charged particles | |
| AU1948788A (en) | Expression of immunologically active proteins of human b-lymphotropic virus | |
| GB846755A (en) | Bovine rhinotracheitis vaccine and methods of production | |
| GB924700A (en) | A process for the continuous production of homogeneous rubber-silicic acid mixtures | |
| GB966540A (en) | Antibiotic separation process | |
| GB938160A (en) | Process for producing a vaccine containing attenuated infectious bovine rhinotracheitis virus and vaccine produced thereby | |
| GB581258A (en) | Improvements in or relating to the treatment of seaweed | |
| GB648861A (en) | Process for the separation of latex into liquid fractions by centrifugal action | |
| GB816577A (en) | Method for preparing vaccines having a specific tissular reaction | |
| GB146260A (en) | A process for preparing proteids charged with immune substances |